Cite
Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice.
MLA
Benrezzak, O., et al. “Antitumor Efficacies of Maltose Tetrapalmitate Immunotherapy Alone and in Combinations with Radiotherapy and with Cyclophosphamide Chemotherapy against Dimethylhydrazine Induced Colon and Anal Cancers in CDI Mice.” Anticancer Research, vol. 8, no. 3, May 1988, pp. 499–506. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3389753&authtype=sso&custid=ns315887.
APA
Benrezzak, O., Madarnas, P., Pageau, R., & Nigam, V. N. (1988). Antitumor efficacies of maltose tetrapalmitate immunotherapy alone and in combinations with radiotherapy and with cyclophosphamide chemotherapy against dimethylhydrazine induced colon and anal cancers in CDI mice. Anticancer Research, 8(3), 499–506.
Chicago
Benrezzak, O, P Madarnas, R Pageau, and V N Nigam. 1988. “Antitumor Efficacies of Maltose Tetrapalmitate Immunotherapy Alone and in Combinations with Radiotherapy and with Cyclophosphamide Chemotherapy against Dimethylhydrazine Induced Colon and Anal Cancers in CDI Mice.” Anticancer Research 8 (3): 499–506. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3389753&authtype=sso&custid=ns315887.